Why do we need noncommercial, investigator-initiated clinical trials?

被引：13
|
作者：
Tyndall, Alan [1 ]
机构：
[1] Univ Basel Hosp, Felix Platter Spital, Dept Rheumatol, CH-4012 Basel, Switzerland
来源：
NATURE CLINICAL PRACTICE RHEUMATOLOGY | 2008年 / 4卷 / 07期
关键词：
D O I：
10.1038/ncprheum0814
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：354 / 355
页数：2
相关论文
共 50 条
  • [31] Ohio CTSAs Implement a Reliant IRB Model for Investigator-Initiated Multicenter Clinical Trials
    Cola, Philip A.
    Reider, Carson
    Strassor, Jane E.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2013, 6 (03): : 176 - 178
  • [32] Development, Review, and Activation of Thoracic Oncology Investigator-Initiated Trials
    Gerber, David E.
    Wynters, Claire R.
    Prasad, Tanushree
    Schnel, Ronny K.
    Zhang, Song
    Stinchcombe, Thomas E.
    Villaruz, Liza C.
    Bauml, Joshua M.
    Iams, Wade T.
    Patil, Tejas
    Liu, Stephen V.
    Horn, Leora
    Hudak, John M.
    Camidge, D. Ross
    CLINICAL CANCER RESEARCH, 2025, 31 (06) : 1103 - 1108
  • [33] Challenges for Academic Investigator-Initiated Pediatric Trials for Rare Diseases
    Ahmed, Raees
    Duerr, Ulrike
    Gavenis, Karsten
    Hilgers, Reinhard
    Gross, Oliver
    CLINICAL THERAPEUTICS, 2014, 36 (02) : 184 - 190
  • [34] The consequences of good clinical practice for investigator-initiated research
    Swank, H. A.
    Morton, D. G.
    Meijer, D. W.
    Bemelman, W. A.
    COLORECTAL DISEASE, 2011, 13 (10) : 1190 - 1192
  • [35] The consequences of good clinical practice for investigator-initiated research
    Swank, H. A.
    Morton, D. G.
    Meijer, D. W.
    Bemelman, W. A.
    COLORECTAL DISEASE, 2012, 14 (01) : 119 - 121
  • [36] Racial Disparities in Clinical Outcomes on Investigator-Initiated Breast Cancer Clinical Trials at an Urban Medical Center
    Aldrich, Jeffrey
    Ekpo, Princess
    Rupji, Manali
    Switchenko, Jeffrey M.
    Torres, Mylin A.
    Kalinsky, Kevin
    Bhave, Manali A.
    CLINICAL BREAST CANCER, 2023, 23 (01) : 38 - 44
  • [37] CHALLENGES AND EQUITY RELATED-ISSUES IN THE CONDUCT OF INVESTIGATOR-INITIATED CLINICAL TRIALS IN KIDNEY DISEASE
    Krishnasamy, Rathika
    Robison, Laura
    Howell, Martin
    Howard, Kirsten
    Reidlinger, Donna
    Shenoy, Aparna
    Mallard, Alistair
    Pascoe, Elaine
    Cho, Yeoungjee
    Viecelli, Andrea
    Roberts, Matthew
    Toussaint, Nigel
    Badve, Sunil
    Peh, Chen Au
    Irish, Ashley
    Johnson, Davidw
    Hawley, Carmel M.
    NEPHROLOGY, 2022, 27 : 43 - 44
  • [38] Navigating investigator-initiated clinical trials: A call for guidelines & monitoring frameworks from an Indian context
    Kumar, Gunjan
    Cherian, Jerin Jose
    Mathur, Roli
    Mukherjee, Aparna
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2024, 160 (02) : 141 - 149
  • [39] Effects of the 12th Amendment to the German Drug Code on Investigator-Initiated Clinical Trials
    Kehrel, U.
    GESUNDHEITSWESEN, 2011, 73 (10) : 696 - 701
  • [40] Comparison of investigator-initiated and industry-initiated trials in Canada and other countries.
    Wong, Bryan
    North, Scott A.
    Ben Tran
    Sridhar, Srikala S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
12345